Skip to content

Assessment of Patient's Satisfaction Regarding the Handiness of Two Hyaluronic Acid Eye Drops Vials

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01546012
Enrollment
0
Registered
2012-03-07
Start date
Unknown
Completion date
Unknown
Last updated
2015-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Assess the Patient Feeling About the Handiness of Two Different Vials Used to Deliver Both, Unpreserved Hyaluronic Eye Drops

Brief summary

Assess the patient feeling about the handiness of two different vials used to deliver both, unpreserved hyaluronic eye drops.

Interventions

DEVICEHYABAK®

Hyaluronic Acid eye drops CE marked, packaged in multidose ABAK® container (preservative free)

Hyaluronic Acid eye drops CE marked, packaged in multidose COMOD® container (preservative free)

Sponsors

Axial Biotech, Inc
CollaboratorINDUSTRY
Laboratoires Thea
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Man or woman aged 18 and older * Patient with dry eye for at least 3 months * Having given his written informed consent

Exclusion criteria

* Intolerance to studied products * Patient's inability to understand the study procedures and give informed consent. * Patient unwilling to follow the study procedures and visits defined by the protocol. * Pregnant or lactating women. * Patient under guardian ship

Design outcomes

Primary

MeasureTime frameDescription
Overall preference of the patient6 weeksAt Visit2: Week 6 +/- 1week: End of Study Visit. Overall preference of the patient: number of answers Hyabak, Hylo-comod.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026